Magnesium for newborns with hypoxic-ischemic encephalopathy: A systematic review and meta-analysis

Journal of Perinatology

Volumn 33, Issue 9, 2013, Pages 663-669

  Tagin, M ^a   Shah, P S ^b   Lee, K S ^c  

^a WINNIPEG REGIONAL HEALTH AUTHORITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

HIE; magnesium; neuroprotection; newborn; review

Indexed keywords

DOPAMINE; MAGNESIUM SULFATE; PLACEBO;

ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPOTENSION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; META ANALYSIS; NEUROLOGIC DISEASE; NEWBORN DISEASE; NEWBORN MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

DEVELOPMENTAL DISABILITIES; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; MAGNESIUM COMPOUNDS;

EID: 84883447310     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2013.65     Document Type: Article

References (44)

1. Gonzalez FF, Miller SP. Does perinatal asphyxia impair cognitive function without cerebral palsy?. Arch Dis Child Fetal Neonatal Ed 2006; 91(6): F454-F459.
2. Marlow N, Rose AS, Rands CE, Draper ES. Neuropsychological and educational problems at school age associated with neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed 2005; 90(5): F380-F387.
3. Van Handel M, Swaab H, De Vries LS, Jongmans MJ. Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: A review. Eur J Pediatr 2007; 166(7): 645-654.
4. Low JA, Lindsay BG, Derrick EJ. Threshold of metabolic acidosis associated with newborn complications. Am J Obstet Gynecol 1997; 177(6): 1391-1394.
5. Lawn JE, Cousens S, Zupan J. 4 Million neonatal deaths: When?. Where?. Why?. Lancet 2005; 365(9462): 891-900.
6. Paul VK. Neonatal morbidity: Report of the National Neonatal and Perinatal Database. Indian Pediatr 1999; 36(2): 167-169.
7. Tagin MA, Woolcott CG, Vincer MJ, Whyte RK, Stinson DA. Hypothermia for neonatal hypoxic ischemic encephalopathy: An updated systematic review and meta-analysis. Arch Pediatr Adolesc Med 2012; 166(6): 558-566.
8. Johnston MV, Fatemi A, Wilson MA, Northington F. Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol 2011; 10(4): 372-382.
9. Robertson NJ, Tan S, Groenendaal F, Van Bel F, Juul SE, Bennet L et al. Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?. J Pediatr 2012; 160(4): 544-552.
10. Delivoria-Papadopoulos M, Mishra OP. Mechanisms of perinatal cerebral injury in fetus and newborn. Ann N Y Acad Sci 2000; 900: 159-168.
11. Inder TE, Volpe JJ. Mechanisms of perinatal brain injury. Semin Neonatol 2000; 5(1): 3-16.
12. Choi DW, Hartley DM. Calcium and glutamate-induced cortical neuronal death. Res Publ Assoc Res Nerv Ment Dis 1993; 71: 23-34.
13. McDonald JW, Roeser NF, Silverstein FS, Johnston MV. Quantitative assessment of neuroprotection against NMDA-induced brain injury. Exp Neurol 1989; 106(3): 289-296.
14. Bengtson CP, Dick O, Bading H. A quantitative method to assess extrasynaptic NMDA receptor function in the protective effect of synaptic activity against neurotoxicity. BMC Neurosci 2008; 9: 11.
15. Nowak L, Bregestovski P, Ascher P. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984; 307(5950): 462-465.
16. Goldenberg RL, Rouse DJ. Preterm birth, cerebral palsy and magnesium. Nat Med 1997; 3(2): 146-147.
17. Higgins JPT, Green S (eds) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011, Available from www.cochrane-handbook.org.
18. Bayley N. Bayley Scales of Infant Development. 2nd edn. Psycholgical: San Antonio, TX, USA, 1993.
19. Bayley N. Bayley Scales of Infant and Toddler Development. 3rd edn. Psycholgical: San Antonio, TX, USA, 2006.
20. Griffiths R. The Griffiths mental development scales, 1996 revision. Henley M: Association for research in infant and child development, test agency, 1996.
21. Brunet O, Lé zine I. Le de'veloppement psychologique de la première enfance. EAP, 1983, p175.
22. Knobloch H, Pasamanick B. Gesell and Amatruda's Developmental Diagnosis: The evaluation and management of normal and abnormal neuropsychologic development in infancy and early childhood 1974.
23. Frankenburg WK, Dodds J, Archer P, Shapiro H, Bresnick B. The Denver II: A major revision and restandardization of the Denver Developmental Screening Test. Pediatrics 1992; 89(1): 91-97.
24. Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration 2008.
25. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J 2003; 327(7414): 557-560.
26. Fai GZ, Gao SL, Yan ZH. Efficacy of magnesium sulfate in the treatment of neonatal hypoxic ischemic encephalopathy. Medical Journal of Qilu 2000; 15(2): 90-92.
27. Bhat MA, Charoo BA, Bhat JI, Ahmad SM, Ali SW, Mufti MU. Magnesium sulfate in severe perinatal asphyxia: A randomized, placebo-controlled trial. Pediatrics 2009; 123(5): 764-769.
28. Ichiba H, Tamai H, Negishi H, Ueda T, Kim T-, Sumida Y et al. Randomized controlled trial of magnesium sulfate infusion for severe birth asphyxia. Pediatr Int 2002; 44(5): 505-509.
29. Gathwala G, Khera A, Singh J, Balhara B. Magnesium for neuroprotection in birth asphyxia. J Pediatr Neurosci 2010; 5(2): 102-104.
30. Groenendaal F, Rademaker CM, Toet MC, de Vries LS. Effects of magnesium sulphate on amplitude-integrated continuous EEG in asphyxiated term neonates. Acta Paediatr 2002; 91: 1073-1077.
31. Khashaba MT, Shouman BO, Shaltout AA, Al-Marsafawy HM, Abdel-Aziz MM, Patel K et al. Excitatory amino acids and magnesium sulfate in neonatal asphyxia. Brain Dev 2006; 28: 375-379.
32. Ichiba H, Yokoi T, Tamai H, Ueda T, Kim TJ, Yamano T. Neurodevelopmental outcome of infants with birth asphyxia treated with magnesium sulfate. Pediatr Int 2006; 48(1): 70-75.
33. Levene M, Blennow M, Whitelaw A, Hanko E, Fellman V, Hartley R. Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia. Arch Disease Childhood Fetal Neonatal Edn 1995; 73(3): 174-177.
34. Greenberg MB, Penn AA, Whitaker KR, Kogut EA, El-Sayed YY, Caughey AB et al. Effect of magnesium sulfate exposure on term neonates. J Perinatol 2013; 33(3): 188-193.
35. Peliowski-Davidovich A. Hypothermia for newborns with hypoxic ischemic encephalopathy. Paediatr Child Health (CAN) 2012; 17(1): 41-43.
36. Evans D. Neuroprotection following intrapartum asphyxia: The Randomised Asphyxia Study (RAST). J Neonat Nurs 1996; 2(3): 14-18.
37. Zhu H, Meloni BP, Bojarski C, Knuckey MW, Knuckey NW. Post-ischemic modest hypothermia (35(degrees)C) combined with intravenous magnesium is more effective at reducing CA1 neuronal death than either treatment used alone following global cerebral ischemia in rats. Exp Neurol 2005; 193(2): 361-368.
38. Zhu H, Meloni BP, Moore SR, Majda BT, Knuckey NW. Intravenous administration of magnesium is only neuroprotective following transient global ischemia when present with post-ischemic mild hypothermia. Brain Res 2004; 1014(1-2): 53-60.
39. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009; (1): CD004661.
40. Dunne JT, Miliigan JE, Thomas BW. The effect of magnesium sulfate on anoxia and resuscitation in the neonate. Am J Obstetrics Gynecology 1971; 109(3): 369-374.
41. Flieger K. Magnesium supplementation has probably no effect on perinatal hypoxia (German). Geburtshilfe Frauenheilkd 2008; 68(1): 12.
42. Gathwala G, Khera A, Singh I. Magnesium therapy in birth asphyxia. Indian J Pediatr 2006; 73(3): 209-212.
43. Khashaba MT, Shouman BO, Shaltout AA, Al-Marsafawy HM, Abdel-Aziz MM, Patel K et al. Abstract Pediatric Academic Societies Meeting Baltimore, MD, USA, 2009.
44. Maroszynska I, Sobolewska B, Gulczynska E, Zylinska L, Lerch E, Kicinska M et al. Can magnesium sulfate reduce the risk of cerebral injury after perinatal asphyxia. Acta Poloniae Pharmaceutica 1999; 56(6): 469-473.